dysport 300 enheder pulver til injektionsvæske, opløsning
2care4 aps - clostridium botulinum, type a toxin-haemagglutinin compleks - pulver til injektionsvæske, opløsning - 300 enheder
teriflunomide accord
accord healthcare s.l.u. - teriflunomide - multipel sklerose, recidiverende-remitterende - immunosuppressants, selektiv immunosuppressive - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
dysport 500 enheder pulver til injektionsvæske, opløsning
paranova danmark a/s - clostridium botulinum, type a toxin - pulver til injektionsvæske, opløsning - 500 enheder
dysport 300 enheder pulver til injektionsvæske, opløsning
orifarm a/s - clostridium botulinum, type a toxin-haemagglutinin compleks - pulver til injektionsvæske, opløsning - 300 enheder
doribax
janssen-cilag international nv - doripenem - pneumonia, ventilator-associated; pneumonia, bacterial; urinary tract infections; bacterial infections; cross infection - antibakterielle midler til systemisk brug, - doribax er indiceret til behandling af følgende infektioner hos voksne:nosokomiel pneumoni (herunder ventilator-associeret pneumoni);kompliceret, intra-abdominale infektioner;komplicerede urinvejsinfektioner. det bør overvejes at officielle vejledning om hensigtsmæssig brug af antibakterielle midler..
ecalta
pfizer europe ma eeig - anidulafungin - candidiasis - antimykotika til systemisk brug - behandling af invasiv candidiasis hos voksne og pædiatriske patienter i alderen 1 måned til < 18 år.
hizentra
csl behring gmbh - human normal immunoglobulin (scig) - immunologiske mangelsyndromer - immune sera og immunoglobuliner, - replacement therapy in adults, children and adolescents (0-18 years) in:- primary immunodeficiency syndromes with impaired antibody production (see section 4. - secondary immunodeficiencies (sid) in patients who suffer from severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (psaf)* or serum igg level of.
sivextro
merck sharp & dohme b.v. - tedizolid phosphat - soft tissue infections; skin diseases, bacterial - antibacterials for systemic use, , other antibacterials - sivextro is indicated for the treatment of acute bacterial skin and skin structure infections (absssi) in adults and adolescents 12 years of age and older.